Does LENVATINIB Cause Palmar erythema? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Palmar erythema have been filed in association with LENVATINIB (Lenvima). This represents 0.0% of all adverse event reports for LENVATINIB.
11
Reports of Palmar erythema with LENVATINIB
0.0%
of all LENVATINIB reports
0
Deaths
8
Hospitalizations
How Dangerous Is Palmar erythema From LENVATINIB?
Of the 11 reports, 8 (72.7%) required hospitalization.
Is Palmar erythema Listed in the Official Label?
Yes, Palmar erythema is listed as a known adverse reaction in the official FDA drug label for LENVATINIB.
What Other Side Effects Does LENVATINIB Cause?
Diarrhoea (4,262)
Hypertension (4,152)
Fatigue (3,603)
Decreased appetite (3,257)
Malignant neoplasm progression (2,929)
Nausea (2,492)
Blood pressure increased (2,228)
Vomiting (1,962)
Asthenia (1,643)
Malaise (1,602)
What Other Drugs Cause Palmar erythema?
CARBOPLATIN (84)
OXALIPLATIN (50)
CAPECITABINE (39)
PACLITAXEL (35)
TRASTUZUMAB (29)
IBUPROFEN (25)
RITUXIMAB (23)
DOCETAXEL (22)
ROLAPITANT (21)
METHOTREXATE (20)
Which LENVATINIB Alternatives Have Lower Palmar erythema Risk?
LENVATINIB vs LEPONEX
LENVATINIB vs LERCANIDIPINE
LENVATINIB vs LETAIRIS
LENVATINIB vs LETERMOVIR
LENVATINIB vs LETROZOLE